Symbotic (NASDAQ:SYM – Get Rating) is set to issue its quarterly earnings data after the market closes on Monday, August 1st. Analysts expect the company to announce earnings of ($0.03) per share for the quarter.
Symbotic Stock Performance
Shares of SYM opened at $17.90 on Friday. Symbotic has a one year low of $9.01 and a one year high of $28.48.
Analysts Set New Price Targets
Several analysts recently weighed in on the stock. The Goldman Sachs Group assumed coverage on shares of Symbotic in a research note on Monday, July 25th. They issued a “neutral” rating and a $19.00 price objective on the stock. Citigroup assumed coverage on shares of Symbotic in a report on Friday, July 1st. They set a “buy” rating on the stock. Robert W. Baird assumed coverage on shares of Symbotic in a report on Thursday, June 23rd. They issued an “outperform” rating and a $18.00 target price on the stock. Cowen assumed coverage on shares of Symbotic in a report on Tuesday, June 21st. They issued an “outperform” rating and a $18.00 target price on the stock. Finally, William Blair assumed coverage on shares of Symbotic in a report on Friday, July 15th. They issued an “outperform” rating on the stock. One research analyst has rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $19.00.
Symbotic Company Profile
Symbotic Inc, an automation technology company, provides robotics and technology to improve efficiency for retailers and wholesalers in the United States. It offers The Symbotic System, a full-service warehouse automation system that reduces costs, improves efficiency, and maximizes inventory. The company is based in Wilmington, Massachusetts.
- Get a free copy of the StockNews.com research report on Symbotic (SYM)
- MarketBeat: Week in Review 7/25 – 7/29
- Procter’s Earnings Start To Show Weakness In Q4
- The One Question You Have to Ask Before Investing in INTC Stock
- Home Depot: A Beautiful Boring Stock to Navigate a Bear Market
- Could CRISPR Therapeutics be a Moonshot Hiding in Plain Sight?
Receive News & Ratings for Symbotic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Symbotic and related companies with MarketBeat.com's FREE daily email newsletter.